1. Role of exopolysaccharides (EPSs) as anti-Mir-155 in cancer cells
   Ahmed A. Emam et al, 2021, Heliyon CrossRef
2. HNMDA: heterogeneous network-based miRNA–disease association prediction
   Li-Hong Peng et al, 2018, Molecular Genetics and Genomics CrossRef
3. Exosomal microRNAs as Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma
   Andrei Sorop et al, 2021, International Journal of Molecular Sciences CrossRef
4. Exosomal miR-155 Derived from Hepatocellular Carcinoma Cells Under Hypoxia Promotes Angiogenesis in Endothelial Cells
   Yusuke Matsuura et al, 2019, Digestive Diseases and Sciences CrossRef
5. MiR-155 and MiR-665 role as potential non-invasive biomarkers for hepatocellular carcinoma in Egyptian patients with chronic hepatitis C virus infection
   Amal Ahmed Mohamed et al, 2020, Journal of Translational Internal Medicine CrossRef
6. The Emerging Role of Exosomal miRNAs as Biomarkers for Early Cancer Detection: A Comprehensive Literature Review
   Ali Jafari et al, 2023, Technology in Cancer Research & Treatment CrossRef
7. A meta-analysis of the diagnostic value of microRNA-1246 for malignant tumors
   Chunlin Xie et al, 2019, Medicine CrossRef
8. MicroRNA-296-5p downregulated AKT2 to inhibit hepatocellular carcinoma cell proliferation, migration and invasion
   Xiaojun Ma et al, 2017, Molecular Medicine Reports CrossRef
9. Exosomal microRNAs in hepatocellular carcinoma
   Chenbin Liu et al, 2021, Cancer Cell International CrossRef
10. Small RNA sequencing identified miR-3180 as a potential prognostic biomarker for Chinese hepatocellular carcinoma patients
    Libo Sun et al, 2023, Frontiers in Genetics CrossRef
11. Pegylated interferon-α inhibits the proliferation of hepatocellular carcinoma cells by downregulating miR-155
    Ying Zhang et al, 2019, Annals of Hepatology CrossRef
12. Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients
    Neneng Ratnasari et al, 2022, PLOS ONE CrossRef